Amylyx Pharmaceuticals Inc (AMLX) — Cash Flow Reinvestment Rate
Amylyx Pharmaceuticals Inc (AMLX) has a Cash Flow Reinvestment Rate of 1.57x as of December 2023, reinvesting $21.28 Million (capex $356.00K plus investments $20.93 Million) from operating cash flow of $13.55 Million. Check AMLX cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Amylyx Pharmaceuticals Inc Cash Flow Reinvestment Rate (2023–2023)
Historical reinvestment intensity for Amylyx Pharmaceuticals Inc across 1 annual periods. Explore Amylyx Pharmaceuticals Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year capital reinvestment analysis for Amylyx Pharmaceuticals Inc. For live market cap and broader valuation context, see Amylyx Pharmaceuticals Inc (AMLX) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 13.28x | $158.29 Million | $11.92 Million | $1.24 Million | — |